Alexandra J. Lansky, MD, is Professor of Medicine in the section of Cardiology at the Yale School of Medicine and a practicing cardiologist at Yale-New Haven Hospital, in New Haven, CT. Dr. Lansky joined Yale in 2010 as Director of the Yale Heart and Vascular Clinical Research Program and the Cardiovascular Research Center (YCRC), which specializes in the conduct of national and international cardiovascular clinical trials with specific expertise in the evaluation of interventional devices. She most recently received a dual appointment as Chair of Cardiovascular Research at Queen Mary University in London as part of the Yale and London based Barts Heart Center transatlantic research collaboration. From 2004 to 2010 Dr. Lansky was Associate Professor of Medicine at Columbia University College of Physicians and Surgeons, Director of Clinical Services at the Center for Interventional Vascular Therapy, a practicing cardiologist at New York-Presbyterian, and Chief Scientific Officer of the Cardiovascular Research Foundation Clinical Trials Center.Prior to that she was an interventional cardiologist on faculty at Washington Hospital Center in Washington, DC, and at Lenox Hill Hospital in New York, NY.
She has dedicated her career to leading clinical and angiographic evaluations of more than 500 clinical trials in a broad range of ischemic cardiovascular therapeutic areas, including pharmacologic and interventional device trials, many of which are landmark trials in the field and/or leading to FDA approval in the United States. She has served as the principal investigator on numerous national and international imaging studies, device, DES and neuroprotection trials. Dr. Lansky has authored and coauthored over 500 academic peer-reviewed manuscripts in the fields of interventional cardiology, angiography, and women’s cardiovascular health. She chaired the American Heart Association Statement on Interventions in Women and most recently the Academic Research Consortium defining Neurologic Endpoints in clinical cardiovascular trials.
Dr. Lansky has been recognized for her outstanding clinical research contributions with several prestigious awards including: Masters of Arts Privatim from Yale University in 2017; Thompson Reuter’s 2014 and 2016 “Most influential Scientific Minds for Clinical Medicine”; 2012 Wenger Award of Clinical Excellence in Women’s health, Visiting Professor at Fu Wai Hospital, Bejing, China and Honorary Professor, University College London.
Dr. Lansky is board certified in cardiovascular diseases. A graduate of the Medical College of Virginia in Richmond, VA, she received her residency training in internal medicine, cardiology, and interventional cardiology at Washington Hospital Center, Washington DC. Dr. Lansky is a Fellow of the European Society of Cardiology,the American College of Cardiology, the American Heart Association and the Society of Cardiac Angiography and Interventions.
|Visiting Professor, Chinese PLA General Hospital, Beijing China||2018|
|Scholarship Yale Department of Medicine: American Academy on Communication in Healthcare ENRICH||2017|
|YMG Scholarship: Advanced Emerging Leaders Program, Yale School of Management||2017|
|M.A. privatim, Yale University (Honorary Masters of Arts)||2017|
|YMG Scolarship: Emerging Leaders Program, Yale School of Management||2016|
|Thompson Reuter’s 2016 Web of Science Highly Cited Researcher||2016|
|Thompson Reuter’s 2014 Worlds Most Influential Scientific Minds for Clinical Medicine||2014|
|Wender Award of Excellence in Women’s Health Care. WomenHeart: the NationalCoalition of Women with Heart Disease awarded the annual Wenger Award forExcellence in Women’s Health Care, for excellence in medical leadership, and a life long commitment to pursuing gender-based outcomes research||2012|
|Visiting Professor of Cardiology; Fu Wai Hospital, National Center for Cardiovascular Diseases of China, Beijing, China||2012|
|Dihllon Fellow Award||1996|
|ACC / Bristol Myers Squibb Affiliate Travel Award||1995|
|AHA / ACC Genenteck Grant Award||1994|
|American Heart Association, Nation’s Capital Affiliate Research||1993|